Tenet Healthcare (THC) Tops Q2 EPS by 4c
Tweet
Share
E-mail
Get Alerts THC Hot Sheet
Price: $265.05 +0.59%
EPS Growth %: +25.1%
Financial Fact:
Income (loss) from discontinued operations, net of tax: 1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +25.1%
Financial Fact:
Income (loss) from discontinued operations, net of tax: 1M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Tenet Healthcare (NYSE: THC) reported Q2 EPS of $1.11, $0.04 better than the analyst estimate of $1.07. Revenue for the quarter came in at $4.1 billion versus the consensus estimate of $4.78 billion.
GUIDANCE:
Tenet Healthcare sees FY2021 EPS of $5.23-$5.73 vs consensus of $4.35-$5.67.
For earnings history and earnings-related data on Tenet Healthcare (THC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Goldman Sachs Downgrades Vonovia SE (VNA:DR) (VNNVF) to Neutral
- Bernstein SocGen Group Reiterates Outperform Rating on Zydus Lifesciences (ZYDUSLIF:IN)
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
